NOVARTIND

Novartis India Share PriceNovartis India

₹571.00
10.2 (1.82%)
As on 25 March, 2023 | 13:56 BSE: 500672 NSE: NOVARTIND

Novartis India Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Novartis India

Start SIP

Novartis India Share Price

  • Over 1 Month -4.3%
  • Over 3 Month -17.15%
  • Over 6 Month -17.19%
  • Over 1 Year -8.87%

Novartis India Key Statistics

P/E Ratio 25.6
PEG Ratio 0.3
Market Cap Cr 1,410
Price to Book Ratio 2
EPS 16.6
Dividend 1.8
Relative Strength Index 36.88
Money Flow Index 57.65
MACD Signal -13.76
Average True Range 15.19

Novartis India Investment Rating

  • Master Rating:
  • Novartis India has an operating revenue of Rs. 400.93 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of -1% needs improvement, ROE of -0% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 32 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Novartis India Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 8010212198
Operating Expenses Qtr Cr 73858993
Operating Profit Qtr Cr 816326
Depreciation Qtr Cr 1111
Interest Qtr Cr 0010
Tax Qtr Cr 734-8
Net Profit Qtr Cr 81852-23

Novartis India Technicals

EMA & SMA

Current Price
₹571.
10.2 (1.82%)
  • Bullish Moving Average
  • ___
  • 3
  • Bearish Moving Average
  • ___
  • 13
  • 20 Day
  • 581.94
  • 50 Day
  • 606.83
  • 100 Day
  • 630.23
  • 200 Day
  • 651.57
  • 20 Day
  • 583.65
  • 50 Day
  • 611.47
  • 100 Day
  • 641.99
  • 200 Day
  • 661.07

Novartis India Resistance and Support

PIVOT
₹562.84
Resistance
First Resistance 568.67
Second Resistance 576.54
Third Resistance 582.37
RSI 36.89
MFI 57.65
MACD Single Line -13.76
MACD -14.19
Support
First Resistance 554.97
Second Resistance 549.14
Third Resistance 541.27

Novartis India Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 18,493 898,390 48.58
Week 28,816 2,350,809 81.58
1 Month 12,843 996,617 77.6
6 Month 9,540 582,490 61.06

Novartis India Result Highlights

Novartis India Synopsis

NSE-Medical-Diversified

Novartis is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 399.87 Cr. and Equity Capital is Rs. 12.34 Cr. for the Year ended 31/03/2022. Novartis India Ltd. is a Public Limited Listed company incorporated on 13/12/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1947PLC006104 and registration number is 006104.
Market Cap 1,405
Sales 401
Shares in Float 0.72
No of funds 39
Yield 1.78
Book Value 2.03
U/D Vol ratio 1
LTDebt / Equity
Alpha -0.03
Beta 0.39

Novartis India

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 70.68%70.68%70.68%
Mutual Funds
Insurance Companies 0.76%0.76%0.76%
Foreign Portfolio Investors 0.17%0.17%0.14%
Financial Institutions/ Banks 0.01%0.01%0.01%
Individual Investors 23.01%23.02%22.94%
Others 5.37%5.36%5.47%

Novartis India Management

Name Designation
Mr. Christopher Snook Chairman
Mr. Sanjay Murdeshwar Vice Chairman & Mng.Director
Ms. Monaz Noble Non Exe.Non Ind.Director
Ms. Sandra Martryes Independent Director
Mr. Jai Hiremath Independent Director
Mr. Sanker Parameswaran Independent Director

Novartis India Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Novartis India MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Novartis India FAQs

What is Share Price of Novartis India ?

Novartis India share price is ₹571 As on 25 March, 2023 | 13:42

What is the Market Cap of Novartis India ?

The Market Cap of Novartis India is ₹1409.8 Cr As on 25 March, 2023 | 13:42

What is the P/E ratio of Novartis India ?

The P/E ratio of Novartis India is 25.6 As on 25 March, 2023 | 13:42

What is the PB ratio of Novartis India ?

The PB ratio of Novartis India is 2 As on 25 March, 2023 | 13:42

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number